Hyperbilirubinemia Sara Pape-Salmon NP(F) VIHA, Mental Health & Addictions Services April 13, 2010 Sara Pape-Salmon NP(F) VIHA, Mental Health & Addictions.

Slides:



Advertisements
Similar presentations
Group D Florendo-Gaspar.  Tests based on detoxification and excretory functions  Tests that measure biosynthetic function  Coagulation factors  Other.
Advertisements

Serina Farzin-Nasab, MD Emory University Family Medicine Residency Program.
Approach to a patient with jaundice
CLUES TO THE DIAGNOSIS IN ANEMIA PRINCIPLES 4 Anemia is not a disease 4 There is usually a cause 4 investigation should be logical 4 Start with CBC and.
HYPERBILIRUBINEMI Prof.Dr.Arzu SEVEN. HYPERBILIRUBINEMI (Bilirubin>1mg/dl in blood) Types of bilirubin: İndirect bilirubin=free bilirubin=unconjugated.
College of Medicine, KSU Medical education Department Pathology Department Medical Biochemistry Unit GIT Block (2 nd Year) Integrated Practical (Biochemistry.
Bilirubin Metabolism & Jaundice
RHY/CH00561 Biology of Disease CH0576 Hyperbilirubinaemia & Jaundice II.
Liver Function Tests (LFTs)
1 CLINICAL CHEMISTRY-2 (MLT 302) LIVER FUNCTION AND THE BILIARY TRACT LECTURE FOUR Dr. Essam H. Aljiffri.
Heme Degradation & Hyperbilirubinemias
Sickle Cell Disease Joshua Falto PAs-IV. General Considerations PATHOPHYSIOLOGY 1.A single DNA base change leads to an amino acid substitution of valine.
Heme Degradation & Hyperbilirubinemias Beth A. Bouchard BIOC 212: Biochemistry of Human Disease Spring 2005.
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student rotated under Nephrology Division under the supervision and administration.
Hepatobiliary disease Prepared by: Siti Norhaiza Binti Hadzir.
275 BCH Miss Tahani Al-Shehri
Dr Gihan Gawish. Liver - Anatomy and Physiology Largest organ in the body Three basic functions Metabolic Secretory Vascular Major function Excretion.
By Dr. Abdelaty Shawky Assistant Professor of Pathology
Good Morning! July 19, Semantic Qualifiers Symptoms Acute /subacuteChronic LocalizedDiffuse SingleMultiple StaticProgressive ConstantIntermittent.
MLAB 2401: Clinical Chemistry Keri Brophy-Martinez Alterations in Liver Function.
Liver function tests Lecture 3.
Chapter 15 Bilirubin and Urobilinogen
 Hepatic Pathology and Respiratory System Topics in Human Pathophysiology Fall 2011 Gilead Drug Safety and Public Health.
The Liver & Tests of Hepatic Function
 Tetrapyrrole pigment- a breakdown product of heme  About mg is produced per day primarily in R.E cells of Spleen and Liver  Sources- Breakdown.
HYPERBILIRUBINEMIA Fatima C. Dela Cruz. Jaundice  Yellowish discoloration of the skin, sclera and other mucous membranes of the body.
Bilirubin & Amylase Lab. 10.
Risk factors and Epidemiology of Endometrial and Ovarian Cancer By: Tammy, Merissa, and Heather For: Nursing 519 Unit 6.
Clinical Approach to Neonatal Jaundice
Jaundice Dr. Gehan Mohamed Dr. Abdelaty Shawky.
Gilbert’s syndrome Research Center for Genetic Engineering and Biotechnology “Georgi D. Efremov”, MASA What is Gilbert’s syndrome? Gilbert’s Syndrome is.
MLAB 1415-Hematology Keri Brophy-Martinez Chapter 14: Introduction to Hemolytic Anemias.
Lactate Dehydrogenase: pathophysiologic marker Sara Pape-Salmon NP(F) Mental Health and Addictions Service, VIHA.
Haemolytic Anaemia Elliot Catchpole PCMD.
Therapeutic Plasma Exchange for hyperbilirubinemia in two newborns during Extra Corporeal Membrane Oxygenation Linda Koster-Kamphuis, pediatric nephrologist.
Porphyrins & Bile Pigments. Objectives After studying this chapter, you should be able to: Know the relationship between porphyrins and heme Be familiar.
COMMON ANEMIAS Haematology Dr. Janis Bormanis Common anemias 4 Iron deficiency 4 Megaloblastic anemias 4 Secondary anemias to chronic diseases Anemia.
Pathophysiology. Maximum therapeutic dose: - 4g in adults - 90mg/kg in children Toxicity is with single ingestion of 150 mg/kg or ~7-10 g (adult)
T HE L IVER B ILIRUBIN M ETABOLISM Anson Lowe September 29, 2015.
Dr Vivek Joshi, MD. Heme catabolism  Commonly occurs in liver and spleen  Done by reticuloendothelial cells  Most of the heme for degradation comes.
JAUNDICE Definition:- Jaundice refers to the yellow appearance of the skin, sclerae and mucous membranes resulting from an increased bilirubin concentration.
Bilirubin metabolism and jaundice jaundice. Pathophysiological importance of bilirubin metabolism  It is the end product of heme degradation.  Serum.
Overviw Red cell enzyme Red cell enzyme Glucose-6-phosphate dehydrogenase deficiency Glucose-6-phosphate dehydrogenase deficiency Causes: Causes: Symptoms.
Neonatal Jaundice 新生兒黃疸. History 病人是自然產出生一天大的男嬰;母親 是 24 歲 G2P1A1 客家人,產前實驗室檢 查正常,懷孕過程順利, group B streptococcus 檢查是陰性,母親血型是 O positive ,破水時間是 1 小時。男嬰出 生體重是.
Course of Advanced Diagnostics Integrated laboratory evaluation of liver Prof. Giuseppe Castaldo, a.y
LIVER Liver functions Bile pigment metabolism
MANGEMENT OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY
College of Medicine, KSU Medical education Department Pathology Department Medical Biochemistry Unit GIT Block (2 nd Year) Integrated Practical (Biochemistry.
Liver and biliary tract disorders. Synthesis of plasma proteins Albumin, prealbumin, transferin, coagulations factors…. Detoxication reactions of endogen.
LIVER FUNCTION TESTS
Liver Function Tests (LFTs)
Bilirubin metabolism and jaundice
Liver Function Tests (LFTs)
Bilirubin and Jaundice
Dr. Shumaila Asim Lecture # 8
INVESTIGATION OF HEPATOBILIARY DISEASE
Bilirubin metabolism and jaundice
Integrated Practical (Biochemistry / Pathology)
BY DR WAQAR MBBS, MRCP ASSISTANT PROFESSOR INTERNAL MEDICINE JAUNDICE BY DR WAQAR MBBS, MRCP ASSISTANT PROFESSOR INTERNAL MEDICINE.
Muthana A. Al-Shemeri (M.SC. Clinical Biochemistry)
Blood analysis Lab # 4.
JAUNDICE.
Estimation of Serum Bilirubin (Total & Direct)
Work hard in silence, let your success be your noise
Liver “Function” Test 2013 Mini-Lecture
Hyperbilirubinemia in the setting of antiviral therapy
Bilirubin & Amylase Lab. 10.
Estimation of Serum Bilirubin (Total & Direct)
Icterus differential diagnostics
Presentation transcript:

Hyperbilirubinemia Sara Pape-Salmon NP(F) VIHA, Mental Health & Addictions Services April 13, 2010 Sara Pape-Salmon NP(F) VIHA, Mental Health & Addictions Services April 13, 2010

Demographics  H.H.  64 year-old female  Eastern European descent  Resides in Victoria  H.H.  64 year-old female  Eastern European descent  Resides in Victoria

PMHx:  Paranoid schizophrenia  Obesity  Over-flow incontinence likely  Paranoid schizophrenia  Obesity  Over-flow incontinence likely

PSHx:  Tubal ligation

Medications & Allergies:  Loxapine 25 mg OD  Multivitamin  Folic Acid  Vitamin B12  NKDA  Loxapine 25 mg OD  Multivitamin  Folic Acid  Vitamin B12  NKDA

Social Hx:  Lives alone  No ETOH, currently non-smoker (remote 20 yr hx), no IVD/illicit drug use  Receives intensive MHAS out-reach services  Family hx is not known  Lives alone  No ETOH, currently non-smoker (remote 20 yr hx), no IVD/illicit drug use  Receives intensive MHAS out-reach services  Family hx is not known

Chief Concern  Serum icterus, slight (incidental finding)  Fatigue?  Serum icterus, slight (incidental finding)  Fatigue?

Lab Findings:  Serum indices = slight icterus  ALT, AST = normal  Total bilirubin = high (29 umol/L)  Conjugated bilirubin = normal (3 umol/L)  ? Unconjugated bilirubin (was not obtained/tested)  Serum indices = slight icterus  ALT, AST = normal  Total bilirubin = high (29 umol/L)  Conjugated bilirubin = normal (3 umol/L)  ? Unconjugated bilirubin (was not obtained/tested)

Dx & Pathophysiology  Gilbert Syndrome  Pathophysiology  Most common inherited cause of unconjugated hyperbilirubinemia (recessive trait UGT1 gene)  Underactivity of the conjugating enzyme system (diphospate glucuronyl transferase)  Benign condition  Gilbert Syndrome  Pathophysiology  Most common inherited cause of unconjugated hyperbilirubinemia (recessive trait UGT1 gene)  Underactivity of the conjugating enzyme system (diphospate glucuronyl transferase)  Benign condition

Physiology Review  Bilirubin conjugation  Bilirubin = byproduct of RBC destruction  In plasma bilirubin binds to albumin & is lipid soluble = “unconjugated bilirubin”  Unconjugated bilirubin can cross biologic membranes  Bilirubin conjugation  Bilirubin = byproduct of RBC destruction  In plasma bilirubin binds to albumin & is lipid soluble = “unconjugated bilirubin”  Unconjugated bilirubin can cross biologic membranes

Physiology Continued  Bilirubin conjugation cont:  Unconjugated bilirubin moves into sinusoids in the hepatocyte & joins with glucuronic acid & becomes water soluble = “conjugated bilirubin”  Conjugated bilirubin, now H2O soluble, can be excreted  Excreted in urine (sm amt as urobininogen) and in feces (mostly)  Bilirubin conjugation cont:  Unconjugated bilirubin moves into sinusoids in the hepatocyte & joins with glucuronic acid & becomes water soluble = “conjugated bilirubin”  Conjugated bilirubin, now H2O soluble, can be excreted  Excreted in urine (sm amt as urobininogen) and in feces (mostly)

Signs & Symptoms  Usually dx around puberty  Often precipitated by intercurrent illness, dehydration, menstrual periods, stress, fasting states  Abdominal cramps  Fatigue  Malaise  Mild jaundice intermittently in some  Many people are asymptomatic  Usually dx around puberty  Often precipitated by intercurrent illness, dehydration, menstrual periods, stress, fasting states  Abdominal cramps  Fatigue  Malaise  Mild jaundice intermittently in some  Many people are asymptomatic

Differentials  Hemolysis  Hematoma  Rhabdomyolysis  Acute or chronic liver disease  Infections  Cardiac disease  Medications (e.g. Atazanavir, probenicid, some antibiotics)  Thyrotoxicosis  Hemolysis  Hematoma  Rhabdomyolysis  Acute or chronic liver disease  Infections  Cardiac disease  Medications (e.g. Atazanavir, probenicid, some antibiotics)  Thyrotoxicosis

Laboratory Studies  CBC including retics and blood smear (exclude hemolysis, RBC abnormalities)  Lactate dehydrogenase  LFT’s  Conjugated and unconjugated bilirubin  Dx: Normal CBC, retic, blood smear, LFT’s, + unconjugated hyperbilirubinemia on several occasions, + absence of other disease process.  CBC including retics and blood smear (exclude hemolysis, RBC abnormalities)  Lactate dehydrogenase  LFT’s  Conjugated and unconjugated bilirubin  Dx: Normal CBC, retic, blood smear, LFT’s, + unconjugated hyperbilirubinemia on several occasions, + absence of other disease process.

Treatment  Reassurance of benign nature  Normal life expectancy  No dietary or activity restrictions  No medications for treatment  Reassurance of benign nature  Normal life expectancy  No dietary or activity restrictions  No medications for treatment

References:  McCance, K.L., & Huether, S.E. (2002). Pathophysiology: The biologic basis for disease in adults and children. (4th ed). Mosby Inc. St. Louis, Missouri.  Mukherjee, S. (2009). Gilbert Syndrome. Found on-line at overview. overview  McCance, K.L., & Huether, S.E. (2002). Pathophysiology: The biologic basis for disease in adults and children. (4th ed). Mosby Inc. St. Louis, Missouri.  Mukherjee, S. (2009). Gilbert Syndrome. Found on-line at overview. overview